HVP_DT PAS Medtronic

HVP Destination Therapy Post Approval Study (DT PAS)

Key Inclusion Criteria:

1. Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
2. Patient is intended to receive or be treated with a HeartWare HVAD System for use as destination therapy
3. Patient is consented prior to the HVAD implant procedure

Key Exclusion Criteria:

1. Patient who is, or is expected to be inaccessible for follow-up
2. Patient with exclusion criteria required by local law
3. Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results (i.e., no required intervention that could affect interpretation of all-around product safety and or effectiveness)

**Other protocol-defined inclusion/exclusion criteria may apply. Please click on the NCT Number (below) to learn more about the study at clinicaltrials.gov.**
N/A
NCT03681210
Heart and Vascular
Heart Failure
Jacob Abraham MD
Medtronic
Sarah Grant
  • Providence St. Vincent Medical Center